Sure, your right. But the upside here is huge at .50 . Institutional investors wait on that FDA approval. Not many of those ever stay under $1. They should be able to find financing easily now IMO. the books will be clean in a few months. Hold this one in your portfolio I don't think you will be sorry.
Market Data 
Markets 
AI
